BRISBANE, Calif.–(BUSINESS WIRE)–CUTERA, a leading provider of aesthetic and dermatology solutions, announced today that Jeryl “Jeri” Hilleman will join its Board of Directors, effective July 12, 2024.
Ms. Hilleman brings over 30 years of experience in the healthcare industry, with a proven track record in financial leadership, strategic planning, operational excellence, and corporate governance. Her extensive background in life sciences and medical technology, both as a public company CFO and as a corporate director, will be invaluable to Cutera as it continues to innovate, drive toward profitability, and expand its market presence with AviClear and other flagship products.
“We are thrilled to welcome Jeri to our Board of Directors,” said Taylor Harris, CEO of Cutera. “Her deep understanding of the healthcare sector, combined with her financial acumen and operational insights, will be instrumental in guiding Cutera through our next phase of growth. Jeri’s expertise aligns perfectly with our commitment to delivering value to our shareholders and advancing our patient-focused and customer-centric mission within the medical aesthetics field.”
Ms. Hilleman brings extensive experience in life sciences, having served as a public company CFO for close to 20 years. Most recently, she was the Chief Financial Officer of Intersect ENT, Inc., a commercial drug delivery company focusing on patients with ear, nose and throat conditions. Prior to Intersect ENT, Ms. Hilleman served as Chief Financial Officer of other public healthcare companies including Ocera Therapeutics, Inc., a biopharmaceutical company; Amyris, Inc., a renewable products company; and Symyx Technologies, a life sciences automation company. Her leadership has been pivotal in multiple successful capital-raising events and M&A transactions.
Ms. Hilleman also brings significant corporate governance experience to the Cutera board. She has served as the Chair of the Board of Omada Health, as well as Chair of the Audit Committee of multiple companies, including NovoCure, Limited, Minerva Neurosciences, HilleVax, SI-Bone, and XenoPort. Ms. Hilleman received a B.A. in History from Brown University and an M.B.A. from the Wharton School at the University of Pennsylvania.
“I am excited to join Cutera’s Board at this dynamic time,” said Ms. Hilleman. “Cutera’s innovative products and strong market position offer tremendous potential. I look forward to working with the Board and management team to drive growth and profitability, enhance operational efficiency, and create long-term value for our investors.”
About Cutera, Inc.
Cutera is a leading provider of aesthetic and dermatology solutions for practitioners worldwide. For over 25 years, Cutera strives to improve lives through medical aesthetic technologies that are driven by science and powered through partnerships. For more information, call 1-888-4-CUTERA or visit Cutera.com.
